Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 17, 2016
Insider Transaction Report
Form 4
Jones James B
SVP & Chief Medical Officer
Transactions
- Award
Common Stock
2016-06-15+8,750→ 10,250 total - Award
Stock Option (Right to Buy)
2016-06-15+17,500→ 17,500 totalExercise: $40.34Exp: 2026-06-15→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2017, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.